Drug Safety Newsletter 40th Edition
24 February 2011
Topics covered in this edition of the newsletter include:
- Multaq (dronedarone) - association with severe liver injury
- Thelin (sitaxentan) - Marketing Authorisation withdrawal
- Fluoroquinolones and the risk of QT prolongation
- View the Drug Safety newsletter online or via email
- Safe use of insulin pens
- Direct healthcare professional communications
Drug Safety Newsletter 40th Edition